These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6978850)

  • 21. [USE OF INJECTABLE ERYTHROMYCIN ETHYL SUCCINATE IN GENERAL SURGERY].
    AUBERTIN E; SUDRE Y
    J Med Bord; 1964 Nov; 141():1767-71. PubMed ID: 14230074
    [No Abstract]   [Full Text] [Related]  

  • 22. Simultaneous determination of erythromycin ethylsuccinate and its metabolite erythromycin in human plasma using liquid chromatography-electrospray ionization mass spectrometry for clinical study.
    Gu Y; Wang G; Sun J
    J Pharm Biomed Anal; 2006 Feb; 40(3):737-43. PubMed ID: 16376051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatotoxicity of erythromycin ethylsuccinate in a child.
    Phillips KG
    Can Med Assoc J; 1983 Sep; 129(5):411-2. PubMed ID: 6603894
    [No Abstract]   [Full Text] [Related]  

  • 24. Observations on micro-encapsulated erythromycin (Eryc capsule) in the treatment of various infections of adults.
    Münnich D; Békési I; Farkas A
    Ther Hung; 1988; 36(3):109-14. PubMed ID: 3249998
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepatitis due to erythromycin ethylsuccinate].
    Funck-Brentano C; Danan G; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1982 Dec; 6(12):1044-5. PubMed ID: 6984402
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical trial of erythromycin stearate in surgery (44 cases)].
    Lagache G; Proye C
    Lille Med; 1969 Feb; 14(2):98-102. PubMed ID: 5384131
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acute hepatitis caused by erythromycin esters (propionate and ethylsuccinate)].
    Paliard P; Stremsdoerfer N; Moindrot H
    Gastroenterol Clin Biol; 1983 Jan; 7(1):100-1. PubMed ID: 6601598
    [No Abstract]   [Full Text] [Related]  

  • 28. [Davercin--cyclic erythromycin carbonate in the treatment of gonorrhea].
    Stapiński A; Selibórska Z; Rózański J; Kamiński A; Mazurkiewicz W; Mroczkowski TF
    Przegl Dermatol; 1984; 71(3):279-85. PubMed ID: 6395198
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythromycin ethylsuccinate hepatotoxicity.
    Sullivan D; Csuka ME; Blanchard B
    JAMA; 1980 Mar; 243(10):1074. PubMed ID: 6965509
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study on serum and urine concentrations of erythromycin succinate of pyrrolidine-methyl-tetracycline].
    Nuzzolo L; Sanguigni S; Pierangeli L; Longhi M
    Arch Sci Med (Torino); 1968 Sep; 125(9):403-5. PubMed ID: 17340794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals.
    Lakritz J; Wilson WD; Marsh AE; Mihalyi JE
    Vet Ther; 2002; 3(2):189-95. PubMed ID: 19750750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of oral suspensions containing sulfonamides in combination with erythromycin ethylsuccinate.
    Elrod L; Cox RD; Plasz AC
    J Pharm Sci; 1982 Feb; 71(2):161-6. PubMed ID: 6977637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of antibiotics in dentistry.
    Pankey GA
    Compend Contin Educ Gen Dent; 1980; 1(5):324-6, 330-1. PubMed ID: 6802566
    [No Abstract]   [Full Text] [Related]  

  • 34. Endocarditis prophylaxis.
    Dajani AS
    J Am Dent Assoc; 1988 Feb; 116(2):154. PubMed ID: 3257765
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism for the degradation of erythromycin A and erythromycin A 2'-ethyl succinate in acidic aqueous solution.
    Hassanzadeh A; Barber J; Morris GA; Gorry PA
    J Phys Chem A; 2007 Oct; 111(40):10098-104. PubMed ID: 17880049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication for endocarditis prevention.
    Goldstein J
    J Am Dent Assoc; 1989 Feb; 118(2):144. PubMed ID: 2783940
    [No Abstract]   [Full Text] [Related]  

  • 37. The efficacy of azithromycin in the treatment of acute infraorbital space infection.
    Al-Belasy FA; Hairam AR
    J Oral Maxillofac Surg; 2003 Mar; 61(3):310-6. PubMed ID: 12618970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state].
    Potthast H; Schug B; Elze M; Schwerdtle R; Blume H
    Pharmazie; 1995 Jan; 50(1):56-60. PubMed ID: 7886126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatotoxic reaction to erythromycin ethylsuccinate.
    Patel J; Schneider R
    South Med J; 1984 Oct; 77(10):1343-4. PubMed ID: 6333077
    [No Abstract]   [Full Text] [Related]  

  • 40. [Stability of tablet formulation containing erythromycin ethylsuccinate and demeclocycline hydrochloride].
    Giovinazzo C; Puglisi G; Milazzo L; Caruso A; Mazzone G; Bernardini A
    Boll Chim Farm; 1983 Feb; 122(2):109-17. PubMed ID: 6409133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.